Research - AI for pre-screening in a live GA trial
In Boehringer Ingelheim’s JADE trial (clinicaltrials.gov ID NCT06769048), 4 of 46 trial sites used Bitfount’s pre-screening tool with automated image analysis based on Altris AI models. At the four sites running Bitfount s on-premise pre-screening tool, which analyzed routinely collected OCTs locally, increased the enrollment by 2.3x, and screen failure rates for AI-identified patients fell to 38% vs 69% for patients screened conventionally.